163 related articles for article (PubMed ID: 14568262)
1. Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis.
Oh BK; Jo Chae K; Park C; Kim K; Jung Lee W; Han KH; Nyun Park Y
J Hepatol; 2003 Nov; 39(5):786-92. PubMed ID: 14568262
[TBL] [Abstract][Full Text] [Related]
2. An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region.
Sun M; Eshleman JR; Ferrell LD; Jacobs G; Sudilovsky EC; Tuthill R; Hussein MR; Sudilovsky O
Hepatology; 2001 Jun; 33(6):1415-24. PubMed ID: 11391530
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis.
Oh BK; Kim YJ; Park YN; Choi J; Kim KS; Park C
Am J Gastroenterol; 2006 Apr; 101(4):831-8. PubMed ID: 16494581
[TBL] [Abstract][Full Text] [Related]
4. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.
Miura N; Horikawa I; Nishimoto A; Ohmura H; Ito H; Hirohashi S; Shay JW; Oshimura M
Cancer Genet Cytogenet; 1997 Jan; 93(1):56-62. PubMed ID: 9062581
[TBL] [Abstract][Full Text] [Related]
5. Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.
Nault JC; Calderaro J; Di Tommaso L; Balabaud C; Zafrani ES; Bioulac-Sage P; Roncalli M; Zucman-Rossi J
Hepatology; 2014 Dec; 60(6):1983-92. PubMed ID: 25123086
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal instability, telomere shortening, and inactivation of p21(WAF1/CIP1) in dysplastic nodules of hepatitis B virus-associated multistep hepatocarcinogenesis.
Lee YH; Oh BK; Yoo JE; Yoon SM; Choi J; Kim KS; Park YN
Mod Pathol; 2009 Aug; 22(8):1121-31. PubMed ID: 19465904
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesis.
Oh BK; Kim YJ; Park C; Park YN
Am J Pathol; 2005 Jan; 166(1):73-80. PubMed ID: 15632001
[TBL] [Abstract][Full Text] [Related]
8. The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification.
Roncalli M; Roz E; Coggi G; Di Rocco MG; Bossi P; Minola E; Gambacorta M; Borzio M
Hepatology; 1999 Nov; 30(5):1174-8. PubMed ID: 10534338
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of stathmin and elongation factor 1α in precancerous nodules with telomere dysfunction in hepatitis B viral cirrhotic patients.
Ahn EY; Yoo JE; Rhee H; Kim MS; Choi J; Ko JE; Lee JS; Park YN
J Transl Med; 2014 May; 12():154. PubMed ID: 24885363
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis and proliferation in hepatocarcinogenesis related to cirrhosis.
Park YN; Chae KJ; Kim YB; Park C; Theise N
Cancer; 2001 Dec; 92(11):2733-8. PubMed ID: 11753945
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity in precancerous hepatic nodules.
Hytiroglou P; Kotoula V; Thung SN; Tsokos M; Fiel MI; Papadimitriou CS
Cancer; 1998 May; 82(10):1831-8. PubMed ID: 9587114
[TBL] [Abstract][Full Text] [Related]
12. Expression of DNA methyltransferases in multistep hepatocarcinogenesis.
Choi MS; Shim YH; Hwa JY; Lee SK; Ro JY; Kim JS; Yu E
Hum Pathol; 2003 Jan; 34(1):11-7. PubMed ID: 12605361
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activation in human hepatocarcinogenesis.
Hytiroglou P; Theise ND
Am J Gastroenterol; 2006 Apr; 101(4):839-41. PubMed ID: 16635228
[TBL] [Abstract][Full Text] [Related]
14. Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging.
Gatto A; De Gaetano AM; Giuga M; Ciresa M; Siciliani L; Miele L; Riccardi L; Pizzolante F; Rapaccini GL; Gasbarrini A; Giuliante F; Vecchio FM; Pompili M; Bonomo L
Abdom Imaging; 2013 Aug; 38(4):736-44. PubMed ID: 22986351
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress may enhance the malignant potential of human hepatocellular carcinoma by telomerase activation.
Nishikawa T; Nakajima T; Katagishi T; Okada Y; Jo M; Kagawa K; Okanoue T; Itoh Y; Yoshikawa T
Liver Int; 2009 Jul; 29(6):846-56. PubMed ID: 19141026
[TBL] [Abstract][Full Text] [Related]
16. Nonlinear tumor evolution from dysplastic nodules to hepatocellular carcinoma.
Joung JG; Ha SY; Bae JS; Nam JY; Gwak GY; Lee HO; Son DS; Park CK; Park WY
Oncotarget; 2017 Jan; 8(2):2076-2082. PubMed ID: 27409339
[TBL] [Abstract][Full Text] [Related]
17. Preneoplastic lesions in human hepatocarcinogenesis.
Libbrecht L; Desmet V; Roskams T
Liver Int; 2005 Feb; 25(1):16-27. PubMed ID: 15698394
[TBL] [Abstract][Full Text] [Related]
18. Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis.
Um TH; Kim H; Oh BK; Kim MS; Kim KS; Jung G; Park YN
J Hepatol; 2011 May; 54(5):939-47. PubMed ID: 21145824
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease.
Kojima H; Yokosuka O; Imazeki F; Saisho H; Omata M
Gastroenterology; 1997 Feb; 112(2):493-500. PubMed ID: 9024303
[TBL] [Abstract][Full Text] [Related]
20. Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target.
Ningarhari M; Caruso S; Hirsch TZ; Bayard Q; Franconi A; Védie AL; Noblet B; Blanc JF; Amaddeo G; Ganne N; Ziol M; Paradis V; Guettier C; Calderaro J; Morcrette G; Kim Y; MacLeod AR; Nault JC; Rebouissou S; Zucman-Rossi J
J Hepatol; 2021 May; 74(5):1155-1166. PubMed ID: 33338512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]